PL1835917T3 - Środki zawierające kwas foliowy, witaminę B6 i witaminę B12 oraz ich zastosowanie - Google Patents
Środki zawierające kwas foliowy, witaminę B6 i witaminę B12 oraz ich zastosowanieInfo
- Publication number
- PL1835917T3 PL1835917T3 PL06700709T PL06700709T PL1835917T3 PL 1835917 T3 PL1835917 T3 PL 1835917T3 PL 06700709 T PL06700709 T PL 06700709T PL 06700709 T PL06700709 T PL 06700709T PL 1835917 T3 PL1835917 T3 PL 1835917T3
- Authority
- PL
- Poland
- Prior art keywords
- vitamin
- folic acid
- agents containing
- containing folic
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005001479A DE102005001479A1 (de) | 2005-01-12 | 2005-01-12 | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
EP06700709A EP1835917B1 (de) | 2005-01-12 | 2006-01-11 | Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung |
PCT/EP2006/000198 WO2006074918A1 (de) | 2005-01-12 | 2006-01-11 | Mittel, enthaltend folsäure, vitamin b6 und vitamin b12, und dessen verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1835917T3 true PL1835917T3 (pl) | 2013-09-30 |
Family
ID=36283010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06700709T PL1835917T3 (pl) | 2005-01-12 | 2006-01-11 | Środki zawierające kwas foliowy, witaminę B6 i witaminę B12 oraz ich zastosowanie |
Country Status (7)
Country | Link |
---|---|
US (1) | US7994142B2 (pl) |
EP (1) | EP1835917B1 (pl) |
CA (1) | CA2594775C (pl) |
DE (1) | DE102005001479A1 (pl) |
ES (1) | ES2415360T3 (pl) |
PL (1) | PL1835917T3 (pl) |
WO (1) | WO2006074918A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005009379A1 (de) * | 2005-03-01 | 2006-09-07 | Synavit Gmbh | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
DE102006032414A1 (de) * | 2006-07-13 | 2008-01-17 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure, Füllstoffen und Verdickern |
DE102006032413A1 (de) * | 2006-07-13 | 2008-01-17 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure und einem oder mehreren Polyolen |
EP2773355B1 (en) * | 2011-11-05 | 2022-06-08 | South Alabama Medical Science Foundation | Methods, formulations, and kits for rapidly repleting folate levels in women |
KR102684069B1 (ko) | 2017-12-21 | 2024-07-12 | 오사카 유니버시티 | 신경계 질환 치료제 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563126A (en) * | 1986-11-20 | 1996-10-08 | Metabolite Laboratories | Method for treatment and prevention of deficiencies of vitamins B12, folic acid, and B6 |
CA2105177A1 (en) | 1992-09-14 | 1994-03-15 | Willem Jacob Serfontein | Pharmaceutical preparations for lowering homocysteine levels |
US6207651B1 (en) * | 1996-08-02 | 2001-03-27 | Metabolite Laboratories | Method for treatment and prevention of deficiencies of vitamins B12, folic acid, and B6 |
DE4326698C2 (de) | 1993-08-09 | 1997-05-28 | Puetter Medice Chem Pharm | Verwendung einer Kombination aus Folsäure, Vitamin B¶6¶ und Vitamin B¶1¶¶2¶ zur Prophylaxe und Therapie von Arteriosklerose |
US5932624A (en) * | 1995-10-17 | 1999-08-03 | Herbert; Victor D. | Vitamin supplement composition |
US6129918A (en) * | 1998-08-13 | 2000-10-10 | Wakunaga Of America Co., Ltd. | Method and pharmaceutical composition for reducing serum homocysteine concentration |
US6210686B1 (en) * | 1998-12-18 | 2001-04-03 | Beth Israel Deaconess Medical Center | Dietary supplement and method for lowering risk of heart disease |
US6274170B1 (en) * | 1999-02-18 | 2001-08-14 | Richard Heibel | Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same |
US6299896B1 (en) * | 2000-04-13 | 2001-10-09 | Cooper Concepts, Inc. | Multi-vitamin and mineral supplement |
DE10206159A1 (de) * | 2002-02-14 | 2003-08-28 | Kosmas Kg | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
US20050032740A1 (en) | 2003-08-06 | 2005-02-10 | Balaji Venkataraman | Vitamin compositions for the treatment and prevention of vascular disease and dementia |
-
2005
- 2005-01-12 DE DE102005001479A patent/DE102005001479A1/de not_active Withdrawn
-
2006
- 2006-01-11 EP EP06700709A patent/EP1835917B1/de active Active
- 2006-01-11 CA CA2594775A patent/CA2594775C/en not_active Expired - Fee Related
- 2006-01-11 US US11/813,729 patent/US7994142B2/en not_active Expired - Fee Related
- 2006-01-11 WO PCT/EP2006/000198 patent/WO2006074918A1/de active Application Filing
- 2006-01-11 PL PL06700709T patent/PL1835917T3/pl unknown
- 2006-01-11 ES ES06700709T patent/ES2415360T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
CA2594775C (en) | 2013-10-01 |
DE102005001479A1 (de) | 2006-07-20 |
US20080139498A1 (en) | 2008-06-12 |
US7994142B2 (en) | 2011-08-09 |
WO2006074918A1 (de) | 2006-07-20 |
EP1835917B1 (de) | 2013-03-20 |
ES2415360T3 (es) | 2013-07-25 |
EP1835917A1 (de) | 2007-09-26 |
CA2594775A1 (en) | 2006-07-20 |
US20090253649A9 (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2161A (en) | Gravity gradiometer. | |
EP1917072A4 (en) | VITAMIN PREPARATION | |
IL206127A0 (en) | Azolylmethyloxiranes, use thereof and agents containing the same | |
IL186090A0 (en) | Cgrp antagonists, method for the production thereof, and their use as medicaments | |
IL185484A0 (en) | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents | |
IL190423A0 (en) | Selected cgrp antagonists , methods for the production thereof and their use as medicaments | |
EP1962635A4 (en) | LOAD REDUCTION FOR SHOULDER AND USE THEREOF | |
IL189497A0 (en) | Selected cgrp antagonists, methods for the production thereof and their use as medicaments | |
PL1853267T3 (pl) | Środki zawierające kwas foliowy, witaminę B6 i witaminę B12 oraz ich zastosowanie | |
EP1922309A4 (en) | N-PHENYL-2-PYRIMDINAMINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | |
GB2425290B (en) | Bogie | |
PL1835917T3 (pl) | Środki zawierające kwas foliowy, witaminę B6 i witaminę B12 oraz ich zastosowanie | |
SI1755562T1 (sl) | Kontracepcijsko sredstvo, ki vsebuje folno kislino | |
ZA200710146B (en) | New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents | |
IL186851A0 (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
IL190334A0 (en) | Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents | |
IL180894A0 (en) | 1-??-halo-2,2-difluoro-2-deoxy-d-ribofuranose derivatives and processes for the preparation thereof | |
ZAA200501790S (en) | Carabiners | |
EP1773354A4 (en) | COMPOSITIONS OF VITAMIN B12 | |
ZA200710147B (en) | New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents | |
ZAA200501788S (en) | Carabiners | |
IL187419A0 (en) | Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents | |
ZA200805166B (en) | Diphenyl urea derivatives | |
ZA200805851B (en) | Stress-reducer for shoulder and the use thereof | |
GB0514628D0 (en) | 2,6,8-trisubstituted purines and their different uses |